Delivery Order SPE2DR25D2206-SPE2DR26F9MN3
- Not listed
- On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $5,132.40 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 15, 2026, and performance will be executed from the awardee's location in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's parent organization, Cencora, Inc., which holds a...
- The Defense Logistics Agency awarded a delivery order valued at $1,970.34 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on December 19, 2025, with completion scheduled for December 22, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under AmerisourceBergen's broader federal contract portfolio supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,233.95 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg Vaginal Insert (8 count) on January 16, 2026, with completion scheduled for January 20, 2026. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child transaction under AmerisourceBergen's...
- On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $3,178.29 to AmerSourceBergen Drug Corp for Yuvafem 10 micrograms vaginal insert (8-pack). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 8, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,632.18 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18 units). This contract was competitively awarded on January 15, 2026, with an ultimate completion date of January 16, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award utilized firm fixed-price pricing with no set-aside designation. This delivery order is issued under...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency on January 8, 2026, for Yuvafem 10 microgram vaginal inserts (18-count package) with a ceiling value of $1,023.26. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of January 9, 2026. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,946.09 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 micrograms vaginal inserts (8-count packages) on September 4, 2025, with a ceiling value of $1,565.46. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,352.04 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18 count) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, competitively awarded delivery order was fulfilled from the place of performance in Conshohocken, Pennsylvania. The award represents a task order against AmerisourceBergen's parent company, Cencora, Inc.'s, substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Yuvafem 10 MCG Vaginal Insert (8-count package) with a contract ceiling value of $1,942.13. This firm fixed-price delivery order, with an ultimate completion date of July 15, 2025, represents a non-set-aside competitive award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9MN3Delivery Order
On January 22, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,157.43 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 MCG vaginal insert (18-count package). The contract employs firm fixed-price pricing and carries an ultimate completion date of January 23, 2026. This award is a child contract under AmerisourceBergen's parent organization, Cencora, Inc., and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made on a fully competitive, non-set-aside basis, reflecting the company's capability to compete in open federal procurement. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen serves as a critical vendor in the Defense Logistics Agency's Medical Supply Chain, delivering a diverse portfolio of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Department of Defense healthcare operations and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/21/26 |